FDA Approves First Generic of ProAir HFA

February 24, 2020 — The U.S. Food and Drug Administration today approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the treatment or prevention of bronchospasm in patients four years of age and older with reversible…
Source: Topamax